News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vir Biotechnology, Inc. - Common Stock
(NQ:
VIR
)
9.090
-0.230 (-2.47%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vir Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
February 26, 2026
Via
Chartmill
Tuesday's session: top gainers and losers
↗
February 24, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
February 24, 2026
Via
Chartmill
Which stocks are moving before the opening bell on Tuesday?
↗
February 24, 2026
Via
Chartmill
Vir Biotechnology Inc (NASDAQ:VIR) Reports Q4 2025 Revenue Beat and Major Pipeline Updates
↗
February 23, 2026
Via
Chartmill
Vir Biotechnology Stock Set For Premarket Surge? Retail Trader Hopes Swell As ‘Phenomenal’ HDV Data Sets Stage For Gilead Showdown
↗
November 09, 2025
Via
Stocktwits
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership
↗
February 24, 2026
Raymond James analyst Sean McCutcheon upgraded the stock to ‘Strong Buy’ from ‘Outperform’ and lifted his price target to $19 from $12.
Via
Stocktwits
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
↗
February 23, 2026
The company said its current resources are expected to fund operations into the second quarter of 2028.
Via
Stocktwits
Topics
Earnings
Vir Biotechnology (VIR) Earnings Call Transcript
↗
February 23, 2026
Vir Biotechnology (VIR) Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
Earnings Outlook For Vir Biotechnology
↗
May 06, 2025
Via
Benzinga
5 Analysts Have This To Say About Vir Biotechnology
↗
April 17, 2025
Via
Benzinga
7 Analysts Have This To Say About Vir Biotechnology
↗
February 28, 2025
Via
Benzinga
Is Alnylam Pharmaceuticals a Millionaire Maker?
↗
December 07, 2025
This hot biotech stock could have a lot more room to run.
Via
The Motley Fool
This Astera Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
↗
August 29, 2025
Via
Benzinga
This Southwest Gas Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
↗
August 29, 2025
Via
Benzinga
This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
August 28, 2025
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
This Guess Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
↗
August 28, 2025
Via
Benzinga
This Eli Lilly Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday
↗
August 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 27, 2025
Via
Benzinga
Vir (VIR) Q2 Revenue Drops 61%
↗
August 07, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 11, 2025
Via
Benzinga
Where Vir Biotechnology Stands With Analysts
↗
July 11, 2025
Via
Benzinga
Vir Biotechnology Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
May 22, 2025
Via
Benzinga
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
↗
May 12, 2025
Via
Benzinga
Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why
↗
January 10, 2025
Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate cancer with manageable safety.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 08, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Close
